> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Latest FDA Warning Letter
- URL: https://www.fdaweb.com/latest-fda-warning-letter-22/
- Published: 2018-10-09T12:00:00.000Z
- Updated: 2026-09-15T00:36:54.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5142550

FDA has posted its latest batch of Warning Letters that includes one medical product company. It can be accessed by clicking on the link following the summary below:

  
**Becton Dickinson** Franklin Lakes, NJ (9/14): FDA in August inspected the firm’s Franklin, WI manufacturing facility, which makes pre-filled heparin lock flush syringes and pre-filled 0.9% sodium chloride lock flush syringes, and cited it for GMP deficiencies. For example, the firm failed to adequately establish procedures to control environmental conditions. Additionally, it failed to adequately establish and maintain procedures to identify valid statistical techniques required for establishing, controlling, and verifying the acceptability of process capability and product characteristics.  
[https://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm622651.htm](https://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm622651.htm?ref=fdaweb.com)